Clinical significance of serum homocysteine as a biomarker for early diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients
Ye Bin,
Zhu Xiangying,
Zeng Zhifu,
Ji Xiaozhen,
Ji Meixia
Affiliations
Ye Bin
Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Zhu Xiangying
Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Zeng Zhifu
Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Ji Xiaozhen
Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
Ji Meixia
Department of Endocrine, 6th Affiliated Hospital of Wenzhou Medical University, Lishui People’s Hospital, Zhejiang Province 323000, People’s Republic of China
The aim of this study was to investigate the clinical significance of serum homocysteine (Hcy) as a biomarker for early diagnosis of diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM) patients.
